Adrenaclick

Mylan N.V. (NASDAQ: MYL), which has faced a plethora of lawsuits in the past over its EpiPen, is now being saddled with another lawsuit, although this time around the parties involved go beyond the company and the plaintiffs. EpiPen And Its Legal Tussle EpiPen, or an epinephrine auto injector is...

Mylan NV (NASDAQ: MYL) made headlines in 2016 after patients and politicians denounced the inaccessible prices of its branded EpiPen. On Wednesday, the business took another hit as CIGNA Corporation (NYSE: CI) dropped the branded drug from its coverage. Cigna will cover Mylan’s $300 generic...